EC Nutrition

Editorial Volume 19 Issue 6 - 2024

Milk Lactoferrin: A Nutraceutical Supplement Against Cancer

Taherah Mohammadabadi*

Professor, Faculty of Animal Science and Food Technology, Agricultural Sciences and Natural Resources University, Iran

*Corresponding Author: Taherah Mohammadabadi, Professor, Faculty of Animal Science and Food Technology, Agricultural Sciences and Natural Resources University, Iran.
Received: May 20, 2024; Published: May 24, 2024



Introduction

To fight cancer, multiple aspects of therapy are being considered involving suppression of side effects, adjunct and complementary treatments. Many epidemiological studies have revealed the importance of appropriate life style to prevent cancer. A diet containing the anti-cancer agents is proposed to be a suitable strategy to control the risk of cancer [1].

  1. Poullis A., et al. “Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk”. Cancer Epidemiology and Prevention Biomarkers2 (2004): 279-284.
  2. Sah BNP., et al. “Identification of anticancer peptides from bovine milk proteins and their potential roles in management of cancer: a critical review”. Comprehensive Reviews in Food Science and Food Safety2 (2015): 123-138.
  3. Adlerova L., et al. “Lactoferrin: a review”. Veterinarni Medicina9 (2008): 457-468.
  4. Zhang Y., et al. “Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy”. Nutrition Reviews12 (2014): 763-773.
  5. Zhang J., et al. “Effect of bovine lactoferrin and human lactoferrin on the proliferative activity of the osteoblast cell line MC3T3-E1 in vitro”. Journal of Dairy Science3 (2018): 1827-1833.
  6. Cutone A., et al. “Lactoferrin’s anti-cancer properties: safety, selectivity, and wide range of action”. Biomolecules 3 (2020): 456.
  7. Xu X., et al. “Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin”. Journal of Dairy Science6 (2010): 2344-2350.
  8. Chea C., et al. “Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma”. Biochemical and Biophysical Research Communications1-4 (2018): 142-147.
  9. Chea C., et al. “Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma”. PloS one1 (2018): e0191683.
  10. Qu X., et al. “Immunological approaches towards cancer and inflammation: a cross talk”. Frontiers in immunology 9 (2018): 563.
  11. Lepanto MS., et al. “Lactoferrin in aseptic and septic inflammation”. Molecules7 (2019): 1323.
  12. Duarte D., et al. “The effect of bovine milk lactoferrin on human breast cancer cell lines”. Journal of Dairy Science1 (2011): 66-76.
  13. Gibbons JA., et al. “Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer”. BMC Cancer1 (2015): 425.
  14. Jiang R and B Lönnerdal. “Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways”. Biochemistry and Cell Biology1 (2017): 99-109.
  15. Zadvornyi T., et al. “Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro”. Experimental Oncology3 (2018): 184-189.
  16. Bazak R., et al. “Cancer active targeting by nanoparticles: a comprehensive review of literature”. Journal of Cancer Research and Clinical Oncology5 (2015): 769-784.
  17. Suzuki YA., et al. “The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus”. Biochemistry 41 (2008): 10915-10920.

Taherah Mohammadabadi. “Milk Lactoferrin: A Nutraceutical Supplement Against Cancer”. EC Nutrition  19.6 (2024): 01-04.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net